| Dr David An-moo Rim, MD | |
|
42-21 162nd Street, Flushing, NY 11358 | |
| (718) 463-0101 | |
| (914) 713-0036 |
| Full Name | Dr David An-moo Rim |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 42-21 162nd Street, Flushing, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467534131 | NPI | - | NPPES |
| 00585846 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 129036 (New York) | Primary |
| Entity Name | Total Medical Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811006083 PECOS PAC ID: 8921998006 Enrollment ID: O20040319001415 |
News Archive
"Earnings from the nation's big health insurers show signs of a new uptick in medical costs related to the recession: As unemployment rises, people who have lost their jobs or are fearful of losing them are rushing to see doctors to get medical tests before their benefits expire," the Wall Street Journal reports.
Along with the joy of the holiday season comes the usual pressure for families. There are cards to send, cookies to bake, and gifts to wrap. However, one thing most American families don't have to worry this Christmas is finding enough money to protect their children from a life-threatening illness. That's not the case for families like Rachell Chuya and her five children in Zambia.
Genentech, a member of the Roche Group and Biogen Idec announced today that the U.S. Food and Drug Administration (FDA) approved Rituxan® (rituximab), in combination with corticosteroids, as a new medicine for adults with Wegener's Granulomatosis (WG) and Microscopic Polyangiitis (MPA).
Kenyan social enterprise ZanaAfrica Group is recognized as a leading innovator in global health, education and development with the receipt of the highly selective "Phase II Grand Challenges Exploration" grant, a partnership between Grand Challenges Canada (which is funded by the Government of Canada) and The Bill & Melinda Gates Foundation.
Parasport continues to grow worldwide. A new thesis from Lund University in Sweden shows how Paralympic athletes run the risk of both being injured by strenuous training as well as being affected by injuries and illness due to their impairment. The results indicate that the incidence is almost twice as high when compared with similar studies of athletes in Sweden with no disabilities.
› Verified 6 days ago
| Entity Name | Mihail Medvedovsky Physician Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942304001 PECOS PAC ID: 3779474937 Enrollment ID: O20101203000912 |
News Archive
"Earnings from the nation's big health insurers show signs of a new uptick in medical costs related to the recession: As unemployment rises, people who have lost their jobs or are fearful of losing them are rushing to see doctors to get medical tests before their benefits expire," the Wall Street Journal reports.
Along with the joy of the holiday season comes the usual pressure for families. There are cards to send, cookies to bake, and gifts to wrap. However, one thing most American families don't have to worry this Christmas is finding enough money to protect their children from a life-threatening illness. That's not the case for families like Rachell Chuya and her five children in Zambia.
Genentech, a member of the Roche Group and Biogen Idec announced today that the U.S. Food and Drug Administration (FDA) approved Rituxan® (rituximab), in combination with corticosteroids, as a new medicine for adults with Wegener's Granulomatosis (WG) and Microscopic Polyangiitis (MPA).
Kenyan social enterprise ZanaAfrica Group is recognized as a leading innovator in global health, education and development with the receipt of the highly selective "Phase II Grand Challenges Exploration" grant, a partnership between Grand Challenges Canada (which is funded by the Government of Canada) and The Bill & Melinda Gates Foundation.
Parasport continues to grow worldwide. A new thesis from Lund University in Sweden shows how Paralympic athletes run the risk of both being injured by strenuous training as well as being affected by injuries and illness due to their impairment. The results indicate that the incidence is almost twice as high when compared with similar studies of athletes in Sweden with no disabilities.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David An-moo Rim, MD 4221 162nd St, Flushing, NY 11358-4150 Ph: (718) 463-0101 | Dr David An-moo Rim, MD 42-21 162nd Street, Flushing, NY 11358 Ph: (718) 463-0101 |
News Archive
"Earnings from the nation's big health insurers show signs of a new uptick in medical costs related to the recession: As unemployment rises, people who have lost their jobs or are fearful of losing them are rushing to see doctors to get medical tests before their benefits expire," the Wall Street Journal reports.
Along with the joy of the holiday season comes the usual pressure for families. There are cards to send, cookies to bake, and gifts to wrap. However, one thing most American families don't have to worry this Christmas is finding enough money to protect their children from a life-threatening illness. That's not the case for families like Rachell Chuya and her five children in Zambia.
Genentech, a member of the Roche Group and Biogen Idec announced today that the U.S. Food and Drug Administration (FDA) approved Rituxan® (rituximab), in combination with corticosteroids, as a new medicine for adults with Wegener's Granulomatosis (WG) and Microscopic Polyangiitis (MPA).
Kenyan social enterprise ZanaAfrica Group is recognized as a leading innovator in global health, education and development with the receipt of the highly selective "Phase II Grand Challenges Exploration" grant, a partnership between Grand Challenges Canada (which is funded by the Government of Canada) and The Bill & Melinda Gates Foundation.
Parasport continues to grow worldwide. A new thesis from Lund University in Sweden shows how Paralympic athletes run the risk of both being injured by strenuous training as well as being affected by injuries and illness due to their impairment. The results indicate that the incidence is almost twice as high when compared with similar studies of athletes in Sweden with no disabilities.
› Verified 6 days ago
Ms. Min Cai, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4105 College Point Blvd, Suite 1c, Flushing, NY 11355 Phone: 718-321-0558 Fax: 718-321-1672 | |
Dr. David Scott Rubin, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 13847 Horace Harding Expy, Flushing, NY 11367 Phone: 718-461-5813 Fax: 718-321-8095 | |
Xueshu Zhang, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 133-47 Sanford Avenue, Suite 1f, Flushing, NY 11355 Phone: 718-359-5780 Fax: 718-359-5821 | |
Haoxu Ouyang, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 13227 41st Rd # 2c, Flushing, NY 11355 Phone: 718-269-5055 | |
Mu-i Karen Kuo, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 13259 41st Rd, Suite Cb, Flushing, NY 11355 Phone: 718-939-6234 Fax: 718-939-6235 | |
Evan Choi, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 5645 Main St, Flushing, NY 11355 Phone: 718-670-2000 | |
Dr. Mustafa Salehmohamed, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5645 Main St, Wa-100, Flushing, NY 11355 Phone: 718-670-1405 |